Ferlazzo G - Search Results

1

Emerging Evidence and Treatment Perspectives from Randomized Clinical Trials in Systemic Sclerosis: Focus on Interstitial Lung Disease.

Aragona CO, Versace AG, Ioppolo C, La Rosa D, Lauro R, Tringali MC, Tomeo S, Ferlazzo G, Roberts WN, Bitto A, Irrera N, Bagnato G. Aragona CO, et al. Among authors: ferlazzo g. Biomedicines. 2022 Feb 21;10(2):504. doi: 10.3390/biomedicines10020504. Biomedicines. 2022. PMID: 35203713 Free PMC article. Review.

2

HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk.

Bonaccorsi I, Carrega P, Venanzi Rullo E, Ducatelli R, Falco M, Freni J, Miceli M, Cavaliere R, Fontana V, Versace A, Caramori G, David A, Nunnari G, Ferlazzo G. Bonaccorsi I, et al. Among authors: ferlazzo g. Immunol Lett. 2021 Jun;234:44-46. doi: 10.1016/j.imlet.2021.04.007. Epub 2021 Apr 24. Immunol Lett. 2021. PMID: 33905752 Free PMC article. No abstract available.

3

Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.

Sultana J, Mazzaglia G, Luxi N, Cancellieri A, Capuano A, Ferrajolo C, de Waure C, Ferlazzo G, Trifirò G. Sultana J, et al. Among authors: ferlazzo g. Expert Rev Vaccines. 2020 Oct;19(10):919-936. doi: 10.1080/14760584.2020.1825951. Epub 2020 Oct 6. Expert Rev Vaccines. 2020. PMID: 32940090 Review.

4

Role of natural killer cells in the pathogenesis and progression of multiple sclerosis.

Morandi B, Bramanti P, Bonaccorsi I, Montalto E, Oliveri D, Pezzino G, Navarra M, Ferlazzo G. Morandi B, et al. Among authors: ferlazzo g. Pharmacol Res. 2008 Jan;57(1):1-5. doi: 10.1016/j.phrs.2007.11.003. Epub 2007 Nov 17. Pharmacol Res. 2008. PMID: 18182304 Review.

5

Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer.

Ottonello S, Genova C, Cossu I, Fontana V, Rijavec E, Rossi G, Biello F, Dal Bello MG, Tagliamento M, Alama A, Coco S, Boccardo S, Vanni I, Ferlazzo G, Moretta L, Grossi F, Mingari MC, Carrega P, Pietra G. Ottonello S, et al. Among authors: ferlazzo g. Front Immunol. 2020 Feb 7;11:125. doi: 10.3389/fimmu.2020.00125. eCollection 2020. Front Immunol. 2020. PMID: 32117275 Free PMC article.

6

ILC in chronic inflammation, cancer and targeting with biologicals.

De Pasquale C, Campana S, Bonaccorsi I, Carrega P, Ferlazzo G. De Pasquale C, et al. Among authors: ferlazzo g. Mol Aspects Med. 2021 Aug;80:100963. doi: 10.1016/j.mam.2021.100963. Epub 2021 Mar 14. Mol Aspects Med. 2021. PMID: 33726947

7

Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade.

Genova C, Dellepiane C, Carrega P, Sommariva S, Ferlazzo G, Pronzato P, Gangemi R, Filaci G, Coco S, Croce M. Genova C, et al. Among authors: ferlazzo g. Front Immunol. 2022 Jan 7;12:799455. doi: 10.3389/fimmu.2021.799455. eCollection 2021. Front Immunol. 2022. PMID: 35069581 Free PMC article. Review.

8

Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients.

Gembillo G, Siligato R, Cernaro V, Satta E, Conti G, Salvo A, Romeo A, Calabrese V, Sposito G, Ferlazzo G, Santoro D. Gembillo G, et al. Among authors: ferlazzo g. Int Urol Nephrol. 2022 Feb;54(2):395-403. doi: 10.1007/s11255-021-02904-9. Epub 2021 Jun 9. Int Urol Nephrol. 2022. PMID: 34109496

9

Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation.

Morandi B, Costa R, Falco M, Parolini S, De Maria A, Ratto G, Mingari MC, Melioli G, Moretta A, Ferlazzo G. Morandi B, et al. Among authors: ferlazzo g. J Immunol. 2005 Sep 15;175(6):3690-7. doi: 10.4049/jimmunol.175.6.3690. J Immunol. 2005. PMID: 16148114

10

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, Costa R, Ratto G, Forte G, Carrega P, Lui G, Conte R, Strowig T, Moretta A, Münz C, Thiel A, Moretta L, Ferlazzo G. Romagnani C, et al. Among authors: ferlazzo g. J Immunol. 2007 Apr 15;178(8):4947-55. doi: 10.4049/jimmunol.178.8.4947. J Immunol. 2007. PMID: 17404276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page